The combined result indicated that the expression of tissue VEGF had significant association with PFS of patients with ovarian cancer (HR 1.60, 95% CI 1.11–2.31; P=0.01) (Figure 3). The gene discussed is VEGFA; the disease is ovarian carcinoma.